Distinctive Immunomodulatory and Inflammatory Properties of the Escherichia coli Type II Heat-Labile Enterotoxin LT-IIa and Its B Pentamer following Intradermal Administration


Autoria(s): MATHIAS-SANTOS, Camila; RODRIGUES, Juliana F.; SBROGIO-ALMEIDA, Maria Elisabete; CONNELL, Terry D.; FERREIRA, Luis C. S.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2011

Resumo

The type I and type II heat-labile enterotoxins (LT-I and LT-II) are strong mucosal adjuvants when they are coadministered with soluble antigens. Nonetheless, data on the parenteral adjuvant activities of LT-II are still limited. Particularly, no previous study has evaluated the adjuvant effects and induced inflammatory reactions of LT-II holotoxins or their B pentameric subunits after delivery via the intradermal (i.d.) route to mice. In the present report, the adjuvant and local skin inflammatory effects of LT-IIa and its B subunit pentamer (LT-IIaB(5)) were determined. When coadministered with ovalbumin (OVA), LT-IIa and, to a lesser extent, LT-IIaB(5) exhibited serum IgG adjuvant effects. In addition, LT-IIa but not LT-IIaB(5) induced T cell-specific anti-OVA responses, particularly in respect to induction of antigen-specific cytotoxic CD8(+) T cell responses. LT-IIa and LT-IIaB(5) induced differential tissue permeability and local inflammatory reactions after i.d. injection. Of particular interest was the reduced or complete lack of local reactions, such as edema and tissue induration, in mice i.d. inoculated with LT-IIa and LT-IIaB(5), respectively, compared with mice immunized with LT-I. In conclusion, the present results show that LT-IIa and, to a lesser extent, LT-IIaB(5) exert adjuvant effects when they are delivered via the i.d. route. In addition, the low inflammatory effects of LT-IIa and LT-IIaB(5) in comparison to those of LT-I support the usefulness of LT-IIa and LT-IIaB(5) as parenterally delivered vaccine adjuvants.

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

CNPq Conselho Nacional do Desenvolvimento Cientifico e Tecnologico

Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

U.S. Public Health Service

U.S. Public Health Service[DE13833]

Identificador

CLINICAL AND VACCINE IMMUNOLOGY, v.18, n.8, p.1243-1251, 2011

1556-6811

http://producao.usp.br/handle/BDPI/28458

10.1128/CVI.00012-11

http://dx.doi.org/10.1128/CVI.00012-11

Idioma(s)

eng

Publicador

AMER SOC MICROBIOLOGY

Relação

Clinical and Vaccine Immunology

Direitos

restrictedAccess

Copyright AMER SOC MICROBIOLOGY

Palavras-Chave #GANGLIOSIDE-BINDING ACTIVITIES #ENHANCES IMMUNE-RESPONSES #CHOLERA-TOXIN #MUCOSAL ADJUVANTS #T-CELLS #VACCINATION #SPECIFICITIES #MUTANT #PERMEABILITY #IMMUNIZATION #Immunology #Infectious Diseases #Microbiology
Tipo

article

original article

publishedVersion